PET–CT imaging in non-small-cell lung cancer

Mark Levine and Jim Julian

Imaging is performed in patients with early-stage non-small-cell lung cancer (NSCLC) for disease staging and to identify the patients most likely to benefit from surgery. Two recent randomised trials compared conventional staging plus PET with conventional staging alone in patients with NSCLC. Patients who underwent PET were more likely to avoid futile thoracic surgery.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.